March 17, 2020 by Chain Drug Review
COVID-19, CVS Health
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health is issued the following response to the COVID-19 outbreak on its website: Companywide COVID-19 preparation Through the work of the CVS Health Emergency Response & Resiliency Team and Infectious Disease Response Team, we continue to actively monitor the current international and domestic environment for coronavirus-related risks and prepare accordingly. Specifically,
March 17, 2020 by Chain Drug Review
Aetna, Aetna Medicare Advantage, Charles Brown, CVS Health, Lexington Clinic
Leading Headlines, Pharmacy
LEXINGTON, Ky. — Aetna, a CVS Health company and Lexington Clinic announced Tuesday that members enrolled in Aetna Medicare Advantage plans now have access to personalized healthcare services throughout the Lexington area. With this new agreement, members gain affordable access to all Lexington Clinic offices and associate practices under Lexington Clinic’s award-winning health program. “Aetna Medicare
March 16, 2020 by Chain Drug Review
CVS Health, The National Kidney Foundation (NKF)
March 16, 2020, News
WOONSOCKET, R.I. — The National Kidney Foundation (NKF) and CVS Kidney Care, a CVS Health company, are partnering on a national campaign to raise awareness of kidney disease, which affects some 37 million people in the U.S. In addition, one in every three American adults, or 33%, are at risk for developing this life-threatening disease.
March 16, 2020 by Chain Drug Review
Aetna, Bartell Drugs, CVS Health, Walmart
March 16, 2020, News
NEW YORK — National and regional pharmacy chains were doing what they could to ease the coronavirus fears of shoppers and employees as the contagion spread. Seattle-based Bartell Drugs shipped more over-the-counter products to stores early this month after experiencing high demand due to concerns related to COVID-19. Bartell’s has two stores in the suburb
March 13, 2020 by Chain Drug Review
COVID-19 pandemic, CVS Health
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health announced that the company will be assisting with COVID-19 testing. The drug chain released the following statement: “Given our physical presence in communities across the country and ability to reach millions of consumers with innovative, local solutions, we’re in a unique position to help address the COVID-19 pandemic. We’re working
March 11, 2020 by Chain Drug Review
CVS Health, Dr. Sree Chaguturu, Point Solutions Management service
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health has added five new health and well-being point solution vendors to its Point Solutions Management service following a comprehensive clinical, security and business evaluation process. Point Solutions Management is a full-service offering that enables CVS Caremark pharmacy benefit management (PBM) clients to simplify contracting, secure lowest price and monitor ongoing performance of
March 9, 2020 by Chain Drug Review
COVID-19 outbreak, CVS Health, Dr. Troyen Brennan
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health is taking additional steps across the company to address the COVID-19 outbreak and protect patient access to medication. “Being committed to the welfare of those we serve means being responsive to evolving needs and acting swiftly. This is particularly true in times of uncertainty,” said Dr. Troyen Brennan, executive vice president
March 6, 2020 by Chain Drug Review
Aetna, COVID-19, CVS Health
Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health announced on Friday several steps to support Aetna members in response to the COVID-19 outbreak. “Supporting the health and well-being of our members and removing barriers to care are among our key areas of focus as we navigate the spread of COVID-19,” said Karen Lynch, president, Aetna and executive vice
March 2, 2020 by Chain Drug Review
CVS Health, CVS Kidney Care, Dr. Alan Lotvin, Satellite Healthcare
Leading Headlines, Pharmacy
WOONSOCKET, R.I. — CVS Kidney Care, a CVS Health company, and Satellite Healthcare announced a strategic relationship to advance the care of patients with kidney disease. CVS Kidney Care and Satellite Healthcare will collaborate to provide comprehensive kidney care, and to expand awareness of and access to transplantation and in-home dialysis – initially in two
February 27, 2020 by Chain Drug Review
CVS Health
Business, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health announced that Eva Boratto, executive vice president and chief financial officer, and Dr. Alan Lotvin, executive vice president and president of CVS Caremark, will be participating in a fireside chat with investors at the Barclays Global Healthcare Conference on March 12, 2020, at approximately 8:30 a.m. ET. An audio webcast
February 24, 2020 by Chain Drug Review
Aetna, Aetna Whole Health – Atlanta, CVS Health
Leading Headlines, Pharmacy
ATLANTA — Aetna, a CVS Health company, is now offering fully insured and self-insured health care network options to its Health Maintenance Organization (HMO) and Exclusive Product Organization (EPO) product portfolios through Aetna Whole Health – Atlanta. As part of the greater metro-Atlanta area launch, two local distinguished health systems, Emory Healthcare and Northside Hospital System,
February 12, 2020 by Chain Drug Review
Aetna, Alec Cunningham, CVS Health, Derica Rice, Dr. Alan Lotvin, Larry Merlo
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health reported Wednesday fourth-quarter earnings and revenue that beat Wall Street’s expectations, aided by higher sales in its pharmacy benefit management business. The company also announced some leadership changes, including the departure of CVS Caremark president Derica Rice and his replacement by Dr. Alan Lotvin, who had led CVS’ transformation efforts.
February 11, 2020 by Chain Drug Review
CVS Health, Karen Lynch
Business, Leading Headlines, Retail News
WOONSOCKET, R.I. — To help provide support to underserved populations across the country, CVS Health invested $67 million in affordable housing in 2019. The investments helped to create more than 2,200 affordable homes with supportive services for individuals and families across 24 cities in six states. CVS Health’s investments in affordable housing – as well
February 3, 2020 by Chain Drug Review
CVS, CVS board of directors, CVS Health, David Dorman, Richard "Dick" Swift, Richard Bracken and Mark Bertolini
Leading Headlines, Pharmacy, Retail News, Uncategorized
WOONSOCKET, R.I. — CVS Health has announced upcoming changes to its board of directors. Richard “Dick” Swift, Richard Bracken and Mark Bertolini will not stand for reelection at the company’s 2020 Annual Meeting. The board will then be reduced from 16 to 13 directors in order to further align with corporate governance best practices. Swift, the former